I received my BSN from University of Vermont and worked overseas prior to returning to graduate school at University of Washington. Following my training, I worked in various outpatient psychiatric settings with a strong interest in treating young adults with treatment resistant depression and PTSD over the last 10 years.

In partnership with Dr. Molly Davis I co-founded Clear Path Psychiatry, an innovative interventional psychiatry practice in Seattle, Washington. We’ve seen the limitations with medications and are excited to provide additional treatment options. We offer deep transcranial magnetic stimulation to treat treatment-resistant depression and obsessive-compulsive disorder, using the Brainsway H1 and H7 coils. We also offer Spravato (intranasal esketamine) as an augmenting agent for patients suffering from depression.

I am currently in a year-long psychedelic assisted therapy fellowship program through Integrative Psychiatry Institute which includes specific intensives in ketamine, psilocybin and MDMA. In the near future we plan to offer intramuscular ketamine with ketamine-assisted psychotherapy for people needing rapid relief from severe, treatment-refractory depression.

Outside of Clear Path I founded Spruce Psychiatric Associates and am an Assistant Teaching Professor at University of Washington.